Human Metapneumovirus: Difference between revisions
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
==Section 1== | ==Section 1== | ||
[[Image:HMPVvaccinetest.png|thumb|300px|right|Results of a VLP vaccine test performed in a mouse model. The study was performed by Lèvy <i>et al</i> in 2013, and the figure demonstrates that their vaccine tests were successful in inducing an immune response in the mice.]] | |||
<br>Include some current research in each topic, with at least one figure showing data.<br> | <br>Include some current research in each topic, with at least one figure showing data.<br> | ||
Revision as of 01:12, 23 April 2013
Introduction
Other examples:
Bold
Italic
Subscript: H2O
Superscript: Fe3+
Section 1
Include some current research in each topic, with at least one figure showing data.
Section 2
Include some current research in each topic, with at least one figure showing data.
Section 3
Include some current research in each topic, with at least one figure showing data.
Conclusion
Overall paper length should be 3,000 words, with at least 3 figures.
References
1. http://cmr.asm.org/content/24/4/734.full.pdf Schildgen, V., van den Hoogen, B., Fouchier, R., Tripp, R. a, Alvarez, R., Manoha, C., Williams, J., and Schildgen, O. (2011) Human Metapneumovirus: lessons learned over the first decade., Clinical microbiology reviews 24, 734–54.
Edited by student of Joan Slonczewski for BIOL 238 Microbiology, 2013, Kenyon College.